Atlas Trials

Long-term Outcomes of Ablation, Liver Resection, and Liver Transplant as First-line Treatment for Solitary HCC of 3 cm or Less

Clinical trial NCT05193253 · COMPLETED

Trial details

NCT number
NCT05193253
Sponsor
University Health Network, Toronto
Status
COMPLETED
Study type
OBSERVATIONAL
Hepatocellular Carcinoma
Start date
2000-02-01
Primary completion
2018-11-30
Enrollment
119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.